Fintel reports that on March 30, 2026, Craig-Hallum initiated coverage of Cryoport (NasdaqCM:CYRX) with a Buy recommendation.
Analyst Price Forecast Suggests 73.91% Upside
As of March 27, 2026, the average one-year price target for Cryoport is $13.60/share. The forecasts range from a low of $9.60 to a high of $16.80. The average price target represents an increase of 73.91% from its latest reported closing price of $7.82 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Cryoport is 375MM, an increase of 112.68%. The projected annual non-GAAP EPS is -0.13.
What is the Fund Sentiment?
There are 177 funds or institutions reporting positions in Cryoport. This is an decrease of 142 owner(s) or 44.51% in the last quarter. Average portfolio weight of all funds dedicated to CYRX is 0.07%, an increase of 9.85%. Total shares owned by institutions decreased in the last three months by 21.37% to 41,945K shares. 
The put/call ratio of CYRX is 0.11, indicating a bullish outlook.
What are Other Shareholders Doing?
Millennium Management holds 3,245K shares representing 6.51% ownership of the company. In its prior filing, the firm reported owning 2,621K shares , representing an increase of 19.23%. The firm increased its portfolio allocation in CYRX by 23.53% over the last quarter.
Fred Alger Management holds 1,755K shares representing 3.52% ownership of the company. In its prior filing, the firm reported owning 1,780K shares , representing a decrease of 1.48%. The firm decreased its portfolio allocation in CYRX by 5.07% over the last quarter.
Thematics Asset Management holds 1,639K shares representing 3.29% ownership of the company. In its prior filing, the firm reported owning 1,915K shares , representing a decrease of 16.86%. The firm increased its portfolio allocation in CYRX by 9.73% over the last quarter.
Assenagon Asset Management holds 1,487K shares representing 2.98% ownership of the company. In its prior filing, the firm reported owning 1,499K shares , representing a decrease of 0.76%. The firm increased its portfolio allocation in CYRX by 1.17% over the last quarter.
UBS Group holds 1,422K shares representing 2.85% ownership of the company. In its prior filing, the firm reported owning 1,332K shares , representing an increase of 6.36%. The firm increased its portfolio allocation in CYRX by 11.94% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
